These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22226738)

  • 1. Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.
    Shirotake S; Miyajima A; Kosaka T; Tanaka N; Kikuchi E; Mikami S; Okada Y; Oya M
    Am J Pathol; 2012 Mar; 180(3):1008-1016. PubMed ID: 22226738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
    Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Oya M
    Prostate; 2011 Oct; 71(14):1510-7. PubMed ID: 21321983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
    Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
    Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
    Chipitsyna G; Gong Q; Gray CF; Haroon Y; Kamer E; Arafat HA
    Endocrinology; 2007 May; 148(5):2198-208. PubMed ID: 17303665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer.
    Kosaka T; Miyajima A; Takayama E; Kikuchi E; Nakashima J; Ohigashi T; Asano T; Sakamoto M; Okita H; Murai M; Hayakawa M
    Prostate; 2007 Jan; 67(1):41-9. PubMed ID: 17044086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer.
    Yasumizu Y; Miyajima A; Kosaka T; Miyazaki Y; Kikuchi E; Oya M
    J Urol; 2014 Jan; 191(1):227-34. PubMed ID: 23954373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice.
    Dol F; Martin G; Staels B; Mares AM; Cazaubon C; Nisato D; Bidouard JP; Janiak P; Schaeffer P; Herbert JM
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):395-405. PubMed ID: 11486244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
    Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
    Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells.
    Tanifuji C; Suzuki Y; Geot WM; Horikoshi S; Sugaya T; Ruiz-Ortega M; Egido J; Tomino Y
    Antioxid Redox Signal; 2005; 7(9-10):1261-8. PubMed ID: 16115031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candesartan inhibits LPS-induced expression increase of toll-like receptor 4 and downstream inflammatory factors likely via angiotensin II type 1 receptor independent pathway in human renal tubular epithelial cells.
    Zhao LQ; Huang JL; Yu Y; Lu Y; Fu LJ; Wang JL; Wang YD; Yu C
    Sheng Li Xue Bao; 2013 Dec; 65(6):623-30. PubMed ID: 24343720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
    Nalla AK; Estes N; Patel J; Rao JS
    Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer.
    Takahashi S; Uemura H; Seeni A; Tang M; Komiya M; Long N; Ishiguro H; Kubota Y; Shirai T
    Prostate; 2012 Oct; 72(14):1559-72. PubMed ID: 22430461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan.
    Martin G; Dol F; Marés AM; Berezowski V; Staels B; Hum DW; Schaeffer P; Herbert JM
    J Cardiovasc Pharmacol; 2004 Feb; 43(2):191-9. PubMed ID: 14716205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1.
    Proudfoot JM; Croft KD; Puddey IB; Beilin LJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):846-53. PubMed ID: 12626661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts.
    Huang W; Wu YL; Zhong J; Jiang FX; Tian XL; Yu LF
    Dig Dis Sci; 2008 May; 53(5):1206-10. PubMed ID: 17934850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages.
    Lee GT; Kwon SJ; Kim J; Kwon YS; Lee N; Hong JH; Jamieson C; Kim WJ; Kim IY
    Br J Cancer; 2018 Mar; 118(5):670-678. PubMed ID: 29381686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
    Candido R; Allen TJ; Lassila M; Cao Z; Thallas V; Cooper ME; Jandeleit-Dahm KA
    Circulation; 2004 Mar; 109(12):1536-42. PubMed ID: 15023892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.